1、There is no evidence that antiplatelet agents reduce atherosclerotic risk in patients with HF.
沒有任何證據(jù)表明，抗血小板制劑降低心衰患者動脈粥樣硬化的危險。

2、Anticoagulants, antiplatelet and vasodilators were not administered 5 days before test.
檢測前停抗凝、抗血小板及擴(kuò)血管藥物5天。

3、Antiplatelet agents play an important role in the treatment of ACS.
因此抗血小板藥物在ACS治療中有著重要的地位。

4、But these antiplatelet drugs also increase the risk of bleeding, including upper GI bleeding.
但是這些抗血小板藥物也增加出血的風(fēng)險，包括上消化道出血。

5、Are taking any blood-thinning drugs or antiplatelet medication
你在服用抗凝藥物（比如華法林，肝素）或者抗血小板聚集藥物（阿司匹林或氯吡格雷）——一般情況下，在結(jié)腸鏡檢前應(yīng)明停止服用這些藥物，以防出血不止。

6、There is currently no robust evidence to support the use of venous antiplatelet agents.
目前尚無足夠的證據(jù)推薦使用靜脈抗血小板制劑。

7、Antiplatelet Therapy: to Intensify or to Moderate?
抗血小板治療：強(qiáng)化抑或適度？

8、So antiplatelet cure conduce to reduce the harmful events of cardia and cerebrovascular disorder.
抗血小板治療有助于減少心、腦血管不良事件的發(fā)生。

antiplatelet翻譯